GlaxoSmithKline - רווח למניה ב-12 החודשים האחרונים GSK

A reliable temperature-controlled logistics network ensures the seamless delivery of GSK plc products. This foundation supports the biopharmaceutical behemoth, which develops cutting-edge vaccines and treatments for rare diseases. The TTM annual volatility of net income per share confirms management efficiency, while -17.80 determines the latest valuation metric. The company's success relies on patent protection and regulatory approval of new drugs.

Year-over-year EPS growth (TTM) measures the dynamics of net income per share over a rolling year, reflecting the efficiency of capital generation. Professionals utilize the annual EPS TTM delta to assess business sustainability and identify anomalies in corporate reporting. A stable range for this indicator confirms the quality of asset management. For GSK plc (GSK), this correlates with the retention of key scientific competencies in vaccine development following restructuring.